Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Medicina Clinica
|
January 21, 1989
[Excessive intake of fats and cholesterol in hypercholesterolemic individuals. Effects of dietary intervention on plasma lipids and lipoprotein cholesterol]
E Ros, D Zambón, E Cusó
Medicina Clinica
|
January 1, 1994
[Screening for hypercholesterolemia]
E Ros, D Zambón, R Tresserras, et al.
Coronary Artery Disease
|
December 1, 1994
In-vitro effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on non-hepatic LDL receptor activity: evidence of lack of stimulatory effect of pravastatin
J Pedreño, J L Sánchez, D Zambón, et al.
Journal of Alzheimer'S Disease : JAD
|
September 6, 2002
Correlation between Apolipoprotein-E polymorphism and Alzheimer's disease pathology
F F Cruz-Sánchez, N Durany, J Thome, et al.
Liver
|
June 1, 1985
Chronic hepatitis: a possible etiology of fatty liver
M Bruguera, D Zambón, E Ros, et al.
The American Journal of Clinical Nutrition
|
January 1, 1995
Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia
D Zambón, E Ros, E Casals, et al.
Archives of Internal Medicine
|
February 1, 1991
Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results
E Ros, D Zambón, A Bertomeu, et al.
Medicina Clinica
|
December 8, 1995
[Carotid atherosclerosis evaluated by two-dimensional ultrasonography in patients with primary hypercholesterolemia]
D Zambón, R Gilabert, E Ros, et al.
Journal of Lipid Research
|
December 6, 2001
Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells
S Muñoz, M Merlos, D Zambón, et al.
British Journal of Clinical Pharmacology
|
March 28, 1998
Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia
M Vázquez, D Zambón, Y Hernández, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Medicina Clinica
|
January 21, 1989
[Excessive intake of fats and cholesterol in hypercholesterolemic individuals. Effects of dietary intervention on plasma lipids and lipoprotein cholesterol]
E Ros, D Zambón, E Cusó
Medicina Clinica
|
January 1, 1994
[Screening for hypercholesterolemia]
E Ros, D Zambón, R Tresserras, et al.
Coronary Artery Disease
|
December 1, 1994
In-vitro effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on non-hepatic LDL receptor activity: evidence of lack of stimulatory effect of pravastatin
J Pedreño, J L Sánchez, D Zambón, et al.
Journal of Alzheimer'S Disease : JAD
|
September 6, 2002
Correlation between Apolipoprotein-E polymorphism and Alzheimer's disease pathology
F F Cruz-Sánchez, N Durany, J Thome, et al.
Liver
|
June 1, 1985
Chronic hepatitis: a possible etiology of fatty liver
M Bruguera, D Zambón, E Ros, et al.
The American Journal of Clinical Nutrition
|
January 1, 1995
Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia
D Zambón, E Ros, E Casals, et al.
Archives of Internal Medicine
|
February 1, 1991
Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results
E Ros, D Zambón, A Bertomeu, et al.
Medicina Clinica
|
December 8, 1995
[Carotid atherosclerosis evaluated by two-dimensional ultrasonography in patients with primary hypercholesterolemia]
D Zambón, R Gilabert, E Ros, et al.
Journal of Lipid Research
|
December 6, 2001
Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells
S Muñoz, M Merlos, D Zambón, et al.
British Journal of Clinical Pharmacology
|
March 28, 1998
Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia
M Vázquez, D Zambón, Y Hernández, et al.
Page
of 2